Conjupro Biotherapeutics
Princeton, US
Founders & leadership
HW
Haixing WangExecutive Officer
QW
Qingxi WangExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$9.3MraisedSep 2023 · 1 investors · OtherRule 506(b)
▶$9.3MraisedSep 2023 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Haixing WangExecutive Officer
- Qingxi WangExecutive Officer, Director
- Offering amount
- $67.5M
- Amount sold
- $9.3M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.